Spyre Therapeutics (SYRE) EBT Margin (QoQ) (2015 - 2023)
Powered by 
Analysis
Spyre Therapeutics (SYRE) EBT Margin (QoQ) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Spyre Therapeutics | 7.53 Bn | 7.53 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -2.22 Mn |
| Mar 31, 2023 | 185,873.00 |
| Dec 31, 2022 | -58,153.00 |
| Sep 30, 2022 | -702,919.00 |
| Jun 30, 2022 | -177,611.00 |
| Mar 31, 2022 | -123,367.00 |
| Dec 31, 2021 | -39,145.00 |
| Sep 30, 2021 | -11,981.00 |
| Jun 30, 2018 | 14,088.00 |
| Mar 31, 2018 | -10,901.00 |
| Dec 31, 2017 | 18,672.00 |
| Sep 30, 2017 | -17,587.00 |
| Jun 30, 2017 | 18,743.00 |
| Mar 31, 2017 | -19,630.00 |
| Dec 31, 2016 | 10,339.00 |
| Sep 30, 2016 | -14,729.00 |
| Jun 30, 2016 | 13,381.00 |
| Mar 31, 2016 | -27,716.00 |
| Dec 31, 2015 | 6,650.00 |
| Sep 30, 2015 | -27,635.00 |